Smith & Nephew, Integra Lifesciences and Zimmer Biomet Are Dominating the Market for Global Wound Debridement Devices Market in 2017

Global Wound Debridement Devices Market is expected to grow at a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Access Full Report:

The global wound debridement devices market highly concentrated to a few big players and rest to local players who cater to domestic markets only. Smith & Nephew dominated the wound debridement devices market accounting for a highest market share in 2017, followed by Integra LifeSciences and Zimmer Biomet. Other players in this market include are Advanced Medical Solutions Group plc., Advancis Medical UK, Arobella Medical, B. Braun Melsungen AG,  BioMonde, BSN medical, Coloplast Group,  DeRoyal Industries, Inc, Hollister Incorporated, ITALIA MEDICA SRL , LOHMANN & RAUSCHER GMBH, Medtronic, Misonix, Mölnlycke Health Care AB, Organogenesis Inc, Olympus Corporation, Söring GmbH  and among others.

Smith & Nephew

Smith & Nephew was founded in 1856 and headquartered in London, U.K. The company’s involved in the production of orthopaedic, reconstruction and trauma products, also in advanced wound management and sports medicine. It operates through knee implants, hip implants, trauma & extremities, sports medicine joint repair, arthroscopic enabling technologies, other surgical businesses, advanced wound care, advanced wound bioactive, advanced wound devices. Market focused segment advanced wound care, advanced wound bioactive, advanced wound devices.

The company had its presence in Africa, America, Asia, Australia, Europe, Middle East. The subsidiaries of the company are Neotherix Ltd (U.K.), Smith and Nephew GMBH (Germany),Bioventus (U.S.), Tenet Medical Engineering Inc (Canada), Smith and Nephew medical Shanghai Co. Ltd (China), Smith and Nephew healthcare Pvt. Ltd (India).

Smith & Nephew which is a global medical technology company opened its new USD 9.43 million State of art Research & Development centre at Hessel road site in Hull. This centre will be one of the most equipped medical device R&D centres in Europe

Integra LifeSciences.:

Integra LifeSciences founded in 1989 headquartered in New Jersey, U.S. Company focus in innovative solutions in orthopaedics, neurosurgery, reconstructive and general surgery.  The company offers codman speciality surgical, orthopaedic and tissue technologies products. Market focused category is orthopaedics and tissue technologies..          

The company is based in New Jersey, U.S. and it has its presence in North America, South America, Europe, Asia-Pacific, Middle East and Africa. Subsidiaries of companies are Miltex Inc (U.S.), Derma Sciences Inc (U.S.), Theken Spine LLC (U.S.), Isotis Ortho biologics Inc (U.S.), Spembly Medical Ltd. (U.K), Confluent Surgical Inc (U.S.), TEI Biosciences Inc (U.S.).

In January, Integra LifeSciences acquired the derma sciences. Through this acquisition Integra accelerate the advanced wound care strategy by addition of amniotic tissue-based products of Derma Sciences

Zimmer Biomet:

Zimmer Biomet was founded in 1927 based in Indiana, U.S. The company offers designing , manufacturing, and marketing of sports medicine, orthopaedic, reconstructive products, biologics, extremities, trauma products, office based technologies, spine craniomaxillofacial, thoracic products, dental implants and related surgical products. The company’s main business segments are knees, hips, S.E.T. Dental in dental implants, spine and CMF and other.  The company offers wound debridement devices through knees, hips, S.E.T. Dental, Spine and CMF. The company has it presence in Europe, Asia-Pacific and America. The subsidiaries are as follows Medtech SA (Switzerland), LDR Holding Corporation (U.S.), Electrobiology LLC (U.S.), Zimmer Germany Gmbh (Germany), Zimmer Knee Creations Inc (U.S.).